Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Hao Guo, Yumei Zhang, Heng Ma, Peiyou Gong, Yinghong Shi, Wenlei Zhao, Aijie Wang, Ming Liu, Zehua Sun, Fang Wang, Qing Wang & Xinru Ba. (2022) T-stage-specific abdominal visceral fat, haematological nutrition indicators and inflammation as prognostic factors in patients with clear renal cell carcinoma. Adipocyte 11:1, pages 133-142.
Read now
Read now
Yingwei Xie, Wentai Shangguan, Zhiliang Chen, Zaosong Zheng, Yuqing Chen, Qiyu Zhong, Yishan Zhang, Jingying Yang, Dingjun Zhu & Wenlian Xie. (2021) Establishment of Sunitinib-Resistant Xenograft Model of Renal Cell Carcinoma and the Identification of Drug-Resistant Hub Genes and Pathways. Drug Design, Development and Therapy 15, pages 5061-5074.
Read now
Read now
Hao Guo, Wenlei Zhao, Aijie Wang, Mingzhuo Li, Heng Ma, Fang Wang, Qing Wang & Xinru Ba. (2021) The value of sex-specific abdominal visceral fat as measured via CT as a predictor of clear renal cell carcinoma T stage. Adipocyte 10:1, pages 285-292.
Read now
Read now
Jibing Chen, Youyong Lv, Feng Mu & Kecheng Xu. (2019) Long-term response of metastatic renal clear cell carcinoma following a subcutaneous injection of mixed bacterial vaccine: a case report. OncoTargets and Therapy 12, pages 2531-2538.
Read now
Read now
Suayib Yalcin & Sahin Lacin. (2019) Impact of tivozanib on patient outcomes in treatment of advanced renal cell carcinoma. Cancer Management and Research 11, pages 7779-7785.
Read now
Read now
Bernard Escudier, Camillo Porta, Tim Eisen, Jonathan Belsey, Damilola Gibson, Jonathan Morgan & Robert Motzer. (2018) The role of tivozanib in advanced renal cell carcinoma therapy. Expert Review of Anticancer Therapy 18:11, pages 1113-1124.
Read now
Read now
Kevin Zarrabi & Shenhong Wu. (2018) An evaluation of nivolumab for the treatment of metastatic renal cell carcinoma. Expert Opinion on Biological Therapy 18:6, pages 695-705.
Read now
Read now
Niranjan J Sathianathen, Suprita Krishna, J Kyle Anderson, Christopher J Weight, Shilpa Gupta, Badrinath R Konety & Thomas S Griffith. (2017) The current status of immunobased therapies for metastatic renal-cell carcinoma. ImmunoTargets and Therapy 6, pages 83-93.
Read now
Read now
Kathryn E. Beckermann, Douglas B. Johnson & Jeffrey A. Sosman. (2017) PD-1/PD-L1 blockade in renal cell cancer. Expert Review of Clinical Immunology 13:1, pages 77-84.
Read now
Read now
Articles from other publishers (21)
I. B. Kravtsov, V. A. Solodky, A. Yu. Pavlov, A. G. Dzidzaria, S. V. Fastovets & I. V. Khoroshevskaya. (2023) The role of obesity in patients with renal cell carcinoma. Cancer Urology 19:1, pages 17-24.
Crossref
Crossref
Zhengqiang Wan, Yinglei Wang, Cheng Li & Dongbing Zheng. (2023) SLC14A1 is a new biomarker in renal cancer. Clinical and Translational Oncology 25:8, pages 2607-2623.
Crossref
Crossref
Kyle Schuppe, Skyler Burke, Blake Cohoe, Kevin Chang, Raymond S Lance & Henry Mroch. (2023) Atypical Nelson Syndrome Following Right Partial and Left Total Nephrectomy With Incidental Bilateral Total Adrenalectomy of Renal Cell Carcinoma: A Chat Generative Pre-Trained Transformer (ChatGPT)-Assisted Case Report and Literature Review. Cureus.
Crossref
Crossref
Sanjeev Kumar, Vishwajeet Singh, Mukul K Singh & Satya N Sankhwar. (2023) Management of Metastatic Renal Cell Carcinoma in a Tertiary Care Hospital. Cureus.
Crossref
Crossref
Shuo Huang, Qihan Luo, Junhao Huang, Jiale Wei, Sichen Wang, Chunlan Hong, Ping Qiu & Changyu Li. (2022) A Cluster of Metabolic-Related Genes Serve as Potential Prognostic Biomarkers for Renal Cell Carcinoma. Frontiers in Genetics 13.
Crossref
Crossref
Yang Chen, Junjie Ma, Yunze Dong, Ziyu Yang, Na Zhao, Qian Liu, Wei Zhai & Junhua Zheng. (2022) Characteristics of Gut Microbiota in Patients With Clear Cell Renal Cell Carcinoma. Frontiers in Microbiology 13.
Crossref
Crossref
Revati Sharma, George Kannourakis, Prashanth Prithviraj & Nuzhat Ahmed. (2022) Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma. Frontiers in Medicine 9.
Crossref
Crossref
Paško Babić, Natalija Filipović, Lejla Ferhatović Hamzić, Livia Puljak, Katarina Vukojević & Benjamin Benzon. (2022) Potential Influence of Age and Diabetes Mellitus Type 1 on MSH2 (MutS homolog 2) Expression in a Rat Kidney Tissue. Genes 13:6, pages 1053.
Crossref
Crossref
Hamed Ishaq Khouja, Ibraheem Mohammed Ashankyty, Leena Hussein Bajrai, P. K. Praveen Kumar, Mohammad Amjad Kamal, Ahmad Firoz & Mohammad Mobashir. (2022) Multi-staged gene expression profiling reveals potential genes and the critical pathways in kidney cancer. Scientific Reports 12:1.
Crossref
Crossref
Furqan Ali, Jibran Bin Aziz, Shahzaib Saleem, Sania Ishtiaq Khan, Saadat Khan & Sanam I Khan. (2022) Frequency of Acquired Renal Cystic Disease in Patients on Long-Term Hemodialysis and Associated Renal Cell Carcinoma. Cureus.
Crossref
Crossref
Zhengqing Ba, Ying Xiao, Ming He, Dong Liu, Hao Wang, Hanyang Liang & Jiansong Yuan. (2022) Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Yefei Huang, Qinzhi Wang, Yu Tang, Zixuan Liu, Guixiang Sun, Zhaojun Lu & Yansu Chen. (2022) Identification and validation of a cigarette smoke-related five-gene signature as a prognostic biomarker in kidney renal clear cell carcinoma. Scientific Reports 12:1.
Crossref
Crossref
Stanisław Deja, Adam Litarski, Karolina Anna Mielko, Natalia Pudełko-Malik, Wojciech Wojtowicz, Adam Zabek, Tomasz Szydełko & Piotr Młynarz. (2021) Gender-Specific Metabolomics Approach to Kidney Cancer. Metabolites 11:11, pages 767.
Crossref
Crossref
Evgenia Efthymiou, Argyris Siatelis, Christos Liakouras, Georgios Makris, Michael Chrisofos, Alexis Kelekis, Elias Brountzos, Nikolaos Kelekis & Dimitrios Filippiadis. (2021) Computed Tomography-Guided Percutaneous Microwave Ablation for Renal Cell Carcinoma: Impact of Tumor Size on the Progression Survival Rates. Diagnostics 11:9, pages 1618.
Crossref
Crossref
Hongyan Liu, Shishuo Sun, Gang Wang, Mengmeng Lu, Xiaokang Zhang, Xiaohuan Wei, Xiaoge Gao, Chao Huang, Zhen Li, Junnian Zheng & Qing Zhang. (2021) Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity. Frontiers in Oncology 11.
Crossref
Crossref
Michael Friedrich, Christine Stoehr, Simon Jasinski-Bergner, Arndt Hartmann, Sven Wach, Bernd Wullich, André Steven & Barbara Seliger. (2020) Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma. Journal of Translational Medicine 18:1.
Crossref
Crossref
Clarissa Stapleton, Christina Duffy & Jonathan Duplisea. 2020. Oncologic Critical Care. Oncologic Critical Care
1825
1835
.
Ayca Ece Nezir, Burge Ulukan & Dilek Telci. (2019) Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma. Medical Sciences 7:2, pages 24.
Crossref
Crossref
Clarissa Stapleton, Christina Duffy & Jonathan Duplisea. 2019. Oncologic Critical Care. Oncologic Critical Care
1
11
.
Shaojing Zhang, Qingwei Wang & Juanjuan He. (2017) Intake of red and processed meat and risk of renal cell carcinoma: a meta-analysis of observational studies. Oncotarget 8:44, pages 77942-77956.
Crossref
Crossref
Jundong Zhu, Chao Liang, Yibo Hua, Chenkui Miao, Jianzhong Zhang, Aiming Xu, Kai Zhao, Shouyong Liu, Ye Tian, Huiyu Dong, Chao Zhang, Pu Li, Shifeng Su, Chao Qin & Zengjun Wang. (2017) The metastasis suppressor CD82/KAI1 regulates cell migration and invasion via inhibiting TGF-β 1/Smad signaling in renal cell carcinoma. Oncotarget 8:31, pages 51559-51568.
Crossref
Crossref